Overview of antimicrobials Part II, J Kinder, DSA Flashcards
MOA Fluoroquinolones
[ ] dependent, targets DNA gyrase and topoisomerase IV
how does R form to fluoroquinolones
mutation in bacterial chromosome genes encoding DNA gyrase or topoisomerase IV or by active transport out of cell
spectrum of coverage with FQ
E coli, Salmonella, Shigella, Enterobacter, Campylobacter, Neisseria, Pseudomonas, S aureus
limited Strep
Therapeutic use of FQ
UTI, prostatitis, STI, travelers diarrhea, shigellosis, bone, joint, SSTI infections, diabetic foot infections, propylaxis in neutropenic patients
Respiratory specific FQ cover what pathogens
S pneumoniae, H influenzae, Morazella, S aureus, M pneumoniase, C pneumoniae, Legionella
Cipro covers what additional pathogen
pseudomonas
What are the FQs
Cipro, levofloxacin, moxifloxicin
PO, IV, topical
Adverse effects FQs
GI 3-17% (nausea, comiting
CNS: HA, dizziness, rare halucinations
rash photosensitivity
Achilles tendon rupture
What are the aminoglycosides
gentamycin IV, IM, topical
MOA aminoglycosides
[ ] dependent, bind 30S ribosomes and disrupt normal cycle of ribosomal function by interfering with protein synthesis
how do aminoglycosides reach the site of action
diffusion through porin proteins in outer cell membrane of gram negative bacteria and electron transport/Oxygen dependent movement across cytoplasmic membrane
What is the post antibiotic effect of aminoglycosides
residual bactericidal activity after serum [ ] below MIC
how does R form to aminoglycosides
AG metabolizing enzymes, impaired transport of drug into cell, altered ribosomes
Spectrum covered by aminoglycosides
aerobic gram - bacteria
if combined with B lactam of vancomycin then kill gram +
Gentamycin is really active against what microbe
Serratia
Therapeutic use AGs
UTI
if there is R to other agents
pneumonia, HAP, peritoniitis assoc with dialysis
adverse effects of AGs
ototoxicity, nephrotoxicity, NMblock and apnea
What are the tetracyclines and glycylcyclines
doxycycline PO IV
MOA doxy
bacteriostatic, inhibits bacterial protein synthesis by binding 30S ribosomes and preventing access of aminoacyl tRNA to acceptro site on mRNA complex
R to doxy occurs how
decreased influx, acquisition of energy dependent efflux, ribosomal protection proteins, enzymatic inactivation